Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 USD | -8.38% | -1.19% | -9.07% |
Financials (USD)
Sales 2024 * | 113K | Sales 2025 * | 1.78M | Capitalization | 19.96M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -25M | EV / Sales 2024 * | 176 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 11.2 x |
P/E ratio 2024 * |
-0.82
x | P/E ratio 2025 * |
-0.88
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91% |
Latest transcript on AIM ImmunoTech Inc.
1 day | -8.38% | ||
1 week | -1.19% | ||
Current month | -2.08% | ||
1 month | -28.32% | ||
3 months | +0.48% | ||
6 months | -5.44% | ||
Current year | -9.07% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Robert Dickey
DFI | Director of Finance/CFO | 68 | 22-04-03 |
Chief Tech/Sci/R&D Officer | - | 22-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy K. Bryan
BRD | Director/Board Member | 66 | 23-03-27 |
William Mitchell
CHM | Chairman | 89 | 98-06-30 |
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.4 | -8.38% | 101,134 |
24-05-09 | 0.4366 | +2.71% | 64,064 |
24-05-08 | 0.4251 | +0.02% | 137,986 |
24-05-07 | 0.425 | +1.19% | 463,502 |
24-05-06 | 0.42 | +3.75% | 173,772 |
Delayed Quote Nyse, May 10, 2024 at 04:10 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.07% | 19.96M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- AIM Stock